White blood cell count and new-onset atrial fibrillation after cardiac surgery

Int J Cardiol. 2017 Feb 1:228:971-976. doi: 10.1016/j.ijcard.2016.11.038. Epub 2016 Nov 17.

Abstract

Background: Postoperative new-onset atrial fibrillation (PNAF) is the most common complication following cardiac surgery. The inflammatory response, as a potential underlying mechanism, has been extensively studied. In small studies, the white blood cell count (WBC) has been shown to be the only consistent inflammatory marker associated with PNAF. This study aimed to determine the association between perioperative WBC response and PNAF in a larger study cohort.

Methods: Patients ≥18years, undergoing elective cardiac surgery with a preoperative sinus rhythm were included. WBC was routinely measured preoperatively, and daily during the first four postoperative days. Main outcomes were the difference between peak postoperative WBC and neutrophil/lymphocyte ratio (N/L ratio) and preoperative WBC and N/L ratio (ΔWBC and ΔN/L ratio respectively). Development of PNAF was evaluated in all patients with continuous 12-lead ECG monitoring.

Results: 657 patients were included and 277 (42%) developed PNAF. Univariable analyses showed a statistically significant relationship between ΔWBC (P=0.030) and ΔN/L ratio (P=0.002), and PNAF. In multivariable analysis no significant relationship was found between ΔWBC (OR: 1.14 per 1×109/L increase; 95% CI: 0.65-2.03; P=0.645), ΔN/L ratio (OR: 1.65 per 1×109/L increase; 95% CI: 0.94-2.90; P=0.089), and PNAF. Increasing age (OR: 1.08 per year; 95% CI: 1.01-1.16; P=0.022) and (additional) valve surgery (versus CABG) (OR: 4.96; 95% CI: 2.07-6.91; P≤0.001) were associated with PNAF.

Conclusions: The perioperative WBC response and its components were not associated with the development of PNAF.

Keywords: Atrial fibrillation; Cardiac surgery; Inflammatory cells; Inflammatory response; Perioperative care.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Analysis of Variance
  • Atrial Fibrillation / blood
  • Atrial Fibrillation / etiology*
  • Atrial Fibrillation / mortality
  • Biomarkers / blood
  • Cardiac Surgical Procedures / adverse effects*
  • Cardiac Surgical Procedures / methods
  • Cohort Studies
  • Databases, Factual
  • Elective Surgical Procedures / adverse effects*
  • Elective Surgical Procedures / methods
  • Female
  • Follow-Up Studies
  • Hospital Mortality
  • Humans
  • Leukocyte Count / methods*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Netherlands
  • Perioperative Care / methods
  • Postoperative Complications / blood
  • Postoperative Complications / mortality
  • Postoperative Complications / physiopathology
  • Prospective Studies
  • Risk Assessment
  • Survival Analysis

Substances

  • Biomarkers